1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Refractory or Relapsed Solid Tumors: new trials by email Literature Review of Refractory or Relapsed Solid Tumors trials Research Report on Refractory or Relapsed Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Study of Avelumab in Pediatric Cancer Participants Avelumab - Refractory or Relapsed Solid Tumors, Lymphoma | Phase 1 | Terminated | EMD Serono Research & Development Institute, Inc. | 21 | 2018-03-07 | 2024-06-24 |
Central Nervous System Neoplasms (1) · Lymphoma (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
avelumab (1)
EMD Serono Research & Development Institute, Inc. (1)
Belgium (1) · Canada (1) · Denmark (1) · South Korea (1) · United States (1)
2017 (1)